ArticleEpilepsia open2025
Neurologists' perspectives on SUDEP communication: A comparative study across five European countries.
Article in Epilepsia open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Silence around SUDEP and its impact on caregivers of individuals with developmental and epileptic encephalopathies: An international survey.Epilepsia open · 2026Article
- Towards a Unified Research Agenda: International Consensus to Advance Understanding and Prevention of Sudden Unexpected Death in Epilepsy.Epilepsy currents · 2026Review
- SUDEP update 2026: recent advances in experimental and clinical research.Current opinion in neurology · 2026Review
- Neurologists' perspectives on SUDEP communication: A comparative study across five European countries.Epilepsia open · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesThe leading cause of epilepsy mortality is Sudden unexpected death in epilepsy (SUDEP). National and international guidelines recommend that people with epilepsy are counseled on SUDEP risk at the point of diagnosis or at the earliest opportunity. This study compares neurologist views from five European countries on attitudes and relevance of SUDEP communication.
methodsA cross-sectional online survey of 17 Likert questions using validated themes was circulated via different ILAE and/or equivalent organizations using a non-discriminatory exponential snowballing technique, leading to a non-probability sampling. Data were analyzed using descriptive statistics, Kruskal-Wallis, Chi-square, and Fisher's exact tests. Significance was accepted at p < 0.05.
resultsThere were 313 responses from neurologists from across five countries (UK, Norway, Sweden, Spain, Hungary). Significant heterogeneity (4%-53%) was found between neurologists of different countries in discussing SUDEP with a person with newly diagnosed epilepsy. There were significant inter-country differences in the amount of time neurologists spent in epilepsy care generally and SUDEP discussions particularly. Significant inter-country barriers to SUDEP communication included time constraints, clinical complexity, perceived fear of causing distress to the patient, presumed poor ability of patient/carers to comprehend risk, and a self-perceived low risk of SUDEP. SIGNIFICANCE: Despite all international guidelines stating the need/importance to discuss SUDEP with all PWE, there remains hesitation, avoidance, and subjectivity in neurologists having SUDEP-related conversations, more so in mainland European countries (Norway, Sweden, Spain and Hungary) than in the UK. Training and education are required to improve communication, engagement, and decision-making. PLAIN LANGUAGE SUMMARY: Sudden unexpected death in epilepsy (SUDEP) is the leading cause of death in people with epilepsy, and international guidelines recommend discussing this risk early after diagnosis. This study surveyed 313 neurologists from the UK, Norway, Sweden, Spain, and Hungary to understand their views on SUDEP communication. Results showed large differences between countries in how often and how openly neurologists discussed SUDEP. Barriers included time constraints, fear of upsetting patients, and doubts about patients' understanding. UK neurologists were more likely to have these conversations than their European peers. More training is needed to support consistent and effective SUDEP communication across countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.